Activities of Fluconazole and Voriconazole against 1,586 Recent Clinical Isolates of Candida Species Determined by Broth Microdilution, Disk Diffusion, and Etest Methods: Report from The ARTEMIS Global Antifungal Susceptibility Program, 2001
The ARTEMIS Global Antifungal Susceptibility Program (ARTEMIS Program) was initiated in 2001 to provide focused surveillance of the activities of fluconazole and voriconazole against Candida spp. isolated from blood and other normally sterile sites. A total of 1,586 episodes of infection were detect...
שמור ב:
| הוצא לאור ב: | J Clin Microbiol |
|---|---|
| Principais autores: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
2003
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC153922/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12682127/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.41.4.1440-1446.2003 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
